Chemotherapy-enhanced inflammation may lead to the failure of therapy and metastasis
Dinesh VyasCollege of Human Medicine, Michigan State University, East Lansing, MI, USAGieric LaputCollege of Human Medicine, Michigan State University, East Lansing, MI, USAArpita VyasCollege of Human Medicine, Michigan State University, East Lansing, MI, USA
2014en
ABI
Abstract
The lack of therapy and the failure of existing therapy has been a challenge for clinicians in treating various cancers. Doxorubicin, 5-fluorouracil, cisplatin, and paclitaxel are the first-line therapy in various cancers; however, toxicity, resistance, and treatment failure limit their clinical use. Their status leads us to discover and investigate more targeted therapy with more efficacy. In this article, we dissect literature from the patient perspective, the tumor biology perspective, therapy-induced metastasis, and cell data generated in the laboratory.
Identifiers
Citations and references
Cited by 20 references